全文获取类型
收费全文 | 47534篇 |
免费 | 3565篇 |
国内免费 | 1611篇 |
专业分类
耳鼻咽喉 | 214篇 |
儿科学 | 1146篇 |
妇产科学 | 606篇 |
基础医学 | 7635篇 |
口腔科学 | 1132篇 |
临床医学 | 3380篇 |
内科学 | 7214篇 |
皮肤病学 | 887篇 |
神经病学 | 3742篇 |
特种医学 | 738篇 |
外国民族医学 | 11篇 |
外科学 | 3525篇 |
综合类 | 7051篇 |
现状与发展 | 4篇 |
预防医学 | 2116篇 |
眼科学 | 616篇 |
药学 | 7027篇 |
5篇 | |
中国医学 | 2236篇 |
肿瘤学 | 3425篇 |
出版年
2024年 | 95篇 |
2023年 | 844篇 |
2022年 | 2058篇 |
2021年 | 1965篇 |
2020年 | 1580篇 |
2019年 | 1650篇 |
2018年 | 1643篇 |
2017年 | 1576篇 |
2016年 | 1454篇 |
2015年 | 1552篇 |
2014年 | 2523篇 |
2013年 | 2826篇 |
2012年 | 2365篇 |
2011年 | 2815篇 |
2010年 | 2241篇 |
2009年 | 2301篇 |
2008年 | 2319篇 |
2007年 | 2157篇 |
2006年 | 1983篇 |
2005年 | 1901篇 |
2004年 | 1733篇 |
2003年 | 1501篇 |
2002年 | 1248篇 |
2001年 | 1003篇 |
2000年 | 973篇 |
1999年 | 822篇 |
1998年 | 721篇 |
1997年 | 722篇 |
1996年 | 668篇 |
1995年 | 651篇 |
1994年 | 528篇 |
1993年 | 394篇 |
1992年 | 301篇 |
1991年 | 312篇 |
1990年 | 235篇 |
1989年 | 184篇 |
1988年 | 193篇 |
1987年 | 153篇 |
1986年 | 155篇 |
1985年 | 311篇 |
1984年 | 315篇 |
1983年 | 240篇 |
1982年 | 274篇 |
1981年 | 215篇 |
1980年 | 198篇 |
1979年 | 181篇 |
1978年 | 135篇 |
1977年 | 94篇 |
1976年 | 103篇 |
1975年 | 91篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
本研究选择10μg/ml、20μg/ml、40μg/ml浓度的溴氰菊酯处理白纹伊蚊C6/36细胞,以MMC作为阳性对照物,观察溴氰菊酯处理24h后对C6/36细胞染色体畸变率和姐妹染色单体互换(SCE)频率的影响。结果显示,三个浓度的溴氰菊酯对C6/36细胞染色体畸变率均没有显著影响(P<0.05);溴氰菊酯浓度在40μg/ml时可诱导C6/36细胞SCE频率轻度增高(P>0.05),而溴氰菊酯浓度在10μg/ml、20μg/ml时,对C6/36细胞SCE频率没有诱导作用。表明溴氰菊酯对C6/36细胞的遗传学效应较弱 相似文献
52.
The present study examined the influences of dopamine (DA) receptor stimulation on enkephalin (Met5-enkephalin; ME) and tachykinin (substance P; SP) systems of basal ganglia of Sprague-Dawley rats, lesioned as neonates with 6-hydroxydopamine (6-OHDA). It has been proposed that the neonatal 6-OHDA-lesioned rat could serve as a model for the DA deficiency and self-injurious behavior (SIB) observed in the childhood neurological disorder. Lesch-Nyhan syndrome. In agreement with earlier work, the present study found that the neonatal 6-OHDA treatment at 3 days of age, reduced DA and caused an increase in ME and a decrease in SP content in the striatum and substantia nigra, when tested as adults. Administration of the DA precursor, L-dihydroxyphenylalanine (L-DOPA), to lesioned animals, induced SIB; increased DA and DOPAC levels; produced a greater decrease (-64%) in SP levels in the striatum and substantia nigra than was observed with lesion alone (-28%). The L-DOPA-induced decrease in SP levels and the SIB observed in the lesioned animals were blocked by pretreatment with the D1 receptor antagonist, SCH-23390. Moreover, administration of the D1 receptor agonist, SKF-38393, but not the D2 agonist, LY-171555, to lesioned animals mimicked the L-DOPA responses in all respects, except that the agonists did not alter DA or DOPAC levels. None of the DA agonists or antagonists treatments affected lesion-induced increase in ME levels in the striatum. These results indicate for the first time, that SIB precipitated by DA agonists in neonatal dopaminergic denervated animals, is associated with a marked and selective decrease in SP in the striatonigral SP neurons. This process has two components: (a) a retarded development of the SP system due to neonatal dopaminergic denervation: and (b) a depletion of the remaining SP, presumably by enhanced release due to D1 DA receptor-mediated activation of striatonigral SP neurons. 相似文献
53.
The effect of interleukin-1 on iron metabolism in rats was evaluated. Plasma iron decreased from 184 +/- 16 micrograms/dl (mean +/- SE) to 24 +/- 12 at 6 hours after interleukin-1 intramuscular administration in non-fasting rats and 109 +/- 6 micrograms/dl to 12 +/- 1 micrograms/dl in fasting rats, which was significantly lower than in control rats. Ferrokinetic studies showed a more rapid disappearance rate and lower iron turnover in interleukin-1-injected rats. The release of iron from the mononuclear phagocyte system to plasma was studied at 3 h after interleukin-1 administration. Although the percent of radioactivity in plasma of the total injected dose was 3.2 +/- 0.6% in interleukin-1, which was significantly lower than in the control rats (5.4 +/- 0.6%) at 9 h after intravenous injection of 59Fe chondroitin ferrous sulfate, there was no difference between the amount of 59Fe released from the mononuclear phagocyte system over the first 9 h in interleukin-1 and control rats. These data appear to imply that iron release is unimpaired but that, for some reason, there is an enhanced rate of clearance of the 59Fe once it has been released from the mononuclear phagocyte system into the plasma. 相似文献
54.
55.
Effects of antimicrobial agents on spontaneous and endotoxin-induced cytokine release of human peripheral blood mononuclear cells 总被引:2,自引:0,他引:2
U. Krehmeier M. Bardenheuer G. Voggenreiter U. Obertacke F. U. Schade M. Majetschak 《Journal of infection and chemotherapy》2002,8(2):194-197
Because the immunomodulatory effects of antibiotics could possibly influence the degree of the systemic and local response
to infection, knowledge of their intrinsic influence on the host's inflammatory response appears to be essential. Therefore,
this study investigated the effects of frequently used antimicrobial agents (β-lactams, quinolones gentamicin, vancomycin
and metronidazole) on the in-vitro tumor necrosis factor (TNF)-α and interleukin (IL)-6 production of isolated human peripheral
blood mononuclear cells (PBMNC), cultured with or without endotoxin, in comparison with those effects obtained in a whole-blood
assay system. In the presence of ciprofloxacin, ofloxacin, gentamicin, vancomycin, and metronidazole, a significant inhibition
of the endotoxin-stimulated TNF-α production of human peripheral blood mononuclear cells (PBMNC) was found at therapeutic
levels. Only ofloxacin showed a significant inhibitory influence on the endotoxin-induced IL-6 production of PBMNC. In the
whole-blood assay, significant effects were not detectable. None of the antibiotics showed cytotoxicity. It is concluded that,
at present, the direct immunological effects of antibiotics should be interpreted carefully with regard to the experimental
conditions, and regardless of the therapeutic implications. To assess the potential direct immunomodulatory effect of antimicrobial
agents, different cell culture procedures should be used.
Received: October 19, 2001 / Accepted: February 15, 2002 相似文献
56.
Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats 总被引:7,自引:0,他引:7
Surrounding bovine chromaffin cells by a semipermeable membrane may protect the transplanted cells from a host immune response and shield them from the inflammatory process resulting from the surgical trauma. Encapsulation of the chromaffin cells was achieved by inter-facial adsorption of a polycation on a polyanionic colloid matrix in which the chromaffin cells were entrapped. Basal and potassium-evoked release of catecholamines from encapsulated bovine chromaffin cells was analyzed over a 4-week period in vitro. Norepinephrine and dopamine release remained constant over time whereas epinephrine release significantly decreased. The chromaffin cells also retained the capacity for depolarization-elicited catecholamine release 4 weeks following the encapsulation procedure. Morphological analysis revealed the presence of intact chromaffin cells with well-preserved secretory granules. Striatial implantation of chromaffin cell-loaded capsules significantly reduced apomorphine-induced rotation compared to empty polymer capsules in animals lesioned with 6-hydroxydopamne frr at least 4 weeks. Intact chromaffin cells expressing tyrosine hydroxylase and dopamine-β-hydroxylase were observed in all capsules implanted in the striatum for 4 weeks. The assessment of the clinical potential of transplanting encapsulated adrenal chromaffin cells of either allo- or xenogeneic origin for Parkinson's disease will require long-term behavioral studies. The present study suggests, however, that the polymer encapsulation procedure may offer an alternative to adrenal autografts as a source of dopaminergic tissue. 相似文献
57.
We performed an open, double-blind, and long-term study of vigabatrin (gamma-vinyl-GABA, GVG) in patients with treatment-resistant epilepsy who were receiving only one or at most two standard antiepileptic drugs (AEDs). The novel design included a parallel, double-blind, placebo-controlled phase that minimized the number of patients receiving placebo and allowed determination of the optimum dose of GVG for each patient before initiation of the double-blind phase. The study was divided into four phases. The first phase was a 6-week period of baseline observation. In the second phase, GVG was added openly to previous AEDs for 8 weeks. During the first 2 weeks of this phase, the dose of GVG was increased weekly and then, in the absence of adverse effects, was held constant for the next 6 weeks. At the end of this open phase, seizure frequency during the 6 weeks of constant treatment was compared with the baseline seizure frequency for each patient. Patients who experienced reduction greater than 50% in the frequency of any seizure type during the open phase were defined as responders. These responders were then entered into the third and double-blind phase, in which they were randomly allocated wither to continue active GVG treatment or placebo for 8 weeks. Thirty-three patients entered the study; 31 of 33 patients completed the initial open phase. Twenty patients achieved a reduction greater than or equal to 50% in the frequency of one or more seizure types and were eligible for the double-blind phase; 10 were randomized to continue GVG and 10 were randomized to placebo.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
58.
目的观察卡维地洛对不稳定型心绞痛(UAP)患者高敏C反应蛋白(hs-CRP)、白介素-6(IL-6)及细胞间可溶性黏附分子1(sICAM-1)水平的影响。方法UAP患者62例采用完全随机化方法分成对照组(n=30)和治疗组(n=32),在常规抗血小板、扩血管治疗基础上,对照组予美托洛尔(12.5mg,2次/d×3d)口服,治疗组服卡维地洛(6.25mg,2次/d×3d),在治疗前后分别测定hs-CRP、IL-6、sICAM-1值。结果对照组和治疗组在治疗前hs-CRP、IL-6、sICAM-1均无显著性差异;用药后两组3指标均较用药前显著降低(P<0.05);治疗组在用药后IL-6、sI-CAM-1显著低于对照组(P<0.05)。同时,用药后两组患者的心率、血压、心肌耗氧量均较用药前显著降低(P<0.05),治疗组的心肌耗氧量显著低于对照组(P<0.05)。结论卡维地洛可显著降低UAP患者的炎症因子IL-6、sICMA-1水平。 相似文献
59.
60.
目的探讨血肿局部炎症、假膜新血管生成、局部纤溶状况及其在CSDH发生、发展中的作用。进而探讨CSDH的发病机制,并为CSDH的治疗及预防复发提供理论依据。方法以78例CSDH患者作为病例组,20例健康人作为正常对照组。采用ELISA法测定患者血清及血肿液中VEGF及IL-6的含量。比较患者末梢静脉血及血肿液中四种因子的含量变化并与正常对照组比较。结果病例组血肿液FDP、d-dimer检测均为阳性,血液为阴性;正常对照组血液FDP、d-dimer检测均为阴性;病例组血清VEGF含量与正常对照组比较差异无统计学意义。血肿液中VEGF浓度高于血清中。病例组血清IL-6浓度与正常对照组差异无统计学意义,血肿液中IL-6浓度高于血清中。CSDH患者血肿液VEGF、IL-6水平没有相关性。结论CSDH患者血肿液局部纤溶亢进,局部VEGF分泌旺盛,新血管生成活跃,局部炎症活跃,可导致CSDH不断扩大而参与CSDH发病机制。抗炎治疗、抑制VEGF的生理作用、有选择的对病人施行促凝治疗,可成为部分CSDH病人保守治疗及预防复发的有效手段。 相似文献